PH10 (drug)

PH10 is a purported vomeropherine that is under development by Pherin Pharmaceuticals and VistaGen Therapeutics[1] as a nasal spray for the treatment of major depressive disorder.[2][3]

PH10
Clinical data
Other namesPH10A; PH10 NS[1]
Routes of
administration		Intranasal
Legal status
Legal status
  • Investigational

See also

References
  1. PH-10 Nasal Spray - AdisInsight
  2. Liebowitz, MR; Nicolini, H; Monti, L; Hanover, R (2013). "PH 10 may be a new rapidly acting intranasally administered antidepressant". American Society of Clinical Psychopharmacology (ASCP) Annual Meeting, Miami, FL. Cite journal requires |journal= (help)
  3. Jancin, Bruce (2013). "Novel intranasal antidepressant shows results after 1 week". Clinical Psychiatry News. Retrieved 13 January 2016.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.